Affini-T Therapeutics is developing new cell therapies for cancer that could overcome limitations of the first generation of cell therapies. The initial genomic cancer targets of the startup are mutations of KRAS and p53, both of which have proven difficult to drug.
MedCity INVEST 2022at The Ritz Carlton Chicago is a 3 day gathering with numerous opportunities for in-person networking and learning around the latest technologies and investment trends from VCs and successful entrepreneurs.
Medicare's Comprehensive Kidney Care Contracting model spotlights the importance of proactive, coordinated kidney care. It's critical for nephrology practices to start incorporating this patient-centric approach and consider more than just immediate kidney concerns.
One way to reduce discrimination in medicine is for hospitals, clinics and other medical groups to cultivate the attributes of a high-reliability organization, or HRO, loosely defined as "organizations that operate in complex, high-hazard domains for extended periods without serious accidents or catastrophic failures."
By Michael Schroeder Tuesday, March 22, 2022 6:22 PM
The Eko App uses automated disease detection software and is paired with the company's line of smart stethoscopes to analyze heart sounds with FDA-cleared AI algorithms. The redesigned app includes a range of new features to analyze heart sounds and cardiac rhythm for potential problems, the company said.
Little things truly matter. This is especially true in our fight to prevent colon cancer. Colon cancer almost always starts as tiny mushroom-looking, pre-cancerous growths called "polyps". Over a five- to 10-year period, these little 1mm-10mm nothings may evolve into something…cancer. Fortunately, these can be easily removed during a colonoscopy.
In this episode of the MedCity Pivot Podcast, Jonathan Bush talks about his latest venture - Zus Health - through which he wants to help digital health companies share data to create a universal patient off of which new products can be created to serve payers, providers and others with the ultimate goal of improving patient outcomes.
No comments